Thymidylate synthetase, which appears after infection of Escherichia coli with bacteriophage T4, has been partially purified. The Infection of Escherichia coli by T-even and T5 phage markedly stimulates the biosynthesis of the enzyme thymidylate synthetase both in thymine-requiring and thymine-independent bacteria (2, 4). The new enzyme, which appears after phage infection, can be separated from the E. coli host enzyme (6). In the case of T4 infections, the phage locus responsible for the appearance of the second enzyme, the "td" region, has been identified (17, 18) and maps in a cluster of at least five genes controlling sequential metabolic reactions in the synthesis of thymidylate (20) .
Infection of Escherichia coli by T-even and T5 phage markedly stimulates the biosynthesis of the enzyme thymidylate synthetase both in thymine-requiring and thymine-independent bacteria (2, 4). The new enzyme, which appears after phage infection, can be separated from the E. coli host enzyme (6) . In the case of T4 infections, the phage locus responsible for the appearance of the second enzyme, the "td" region, has been identified (17, 18) and maps in a cluster of at least five genes controlling sequential metabolic reactions in the synthesis of thymidylate (20) .
Interestingly, the phage enzyme appears to be non-essential; phage td mutants are able to multiply well in the presence of either the host enzyme or exogenous thymine. However, under certain conditions, viable phage yields from phage td mutants are decreased in comparison to wild type, suggesting that the ability to induce thymidylate synthetase formation confers a selective advantage on wild-type phage (13) . In order to better understand the nature of the phage-induced enzyme and its relationship to the host enzyme, we studied a group of phage mutants presumably involving the thymidylate synthetase gene locus. We were especially interested in characterizing nonsense mutations in the phage enzyme gene, since with such mutants we hoped to observe the effect of amino acid substitution and protein chain termination on the function and tertiary structure of phage thymidylate synthetase.
To achieve the above goals we employed an experimental system consisting of an isogenic set of thymidylate synthetase E. coli mutants of su-, suI (serine), suII (glutamine), and suIII (tyrosine) genotypes infected with T4 td nonsense mutants. For this purpose, a thyminerequiring strain of E. coli was selected which was shown to be unable to synthesize its own thymidylate synthetase. Since the E. coli strain also contained two known amber mutations for tryptophan and lactose, the successful transduction of suppressor genes could be easily monitored. With this system, it was predicted that prematurely terminated phage thymidylate synthetase would result from infection of the su-host with a phage nonsense mutant and that phage thymidylate synthetase with a known amino acid substitution would be obtained from the infection of a su+ strain. The effect of these alternatives at the same site and at different sites within the phage td gene could then be evaluated. This article reports the characterization of the system in which these substitutions can be studied. (9) .
Test for plaque morphology of the T4B td mutants. The methods of Simon and Tessman (18) were used for plating the phage and doing spot tests. The bacterial strains were grown in M9 supplemented with thymidine, B1, tryptophan, and glucose. The Tris-glucose plates had no thymidine in the bottom agar; the 2.5-ml overlay generally contained 20 Mg of thymidine. For spot testing, the plate with its overlay was incubated for 1 h at 37 C before it was spotted with the phage.
Transduction. The basic procedures of Adams (1) were followed for P1 propagation and titration. The procedure of Lennox (10) was followed for the transduction.
Thymidylate synthetase assays. The major assay for thymidylate synthetase was the spectrophotometric assay of Wahba and Friedkin (20) . The radioactiv- (3, 19) . About 106 cells/ml were introduced into tubes containing supplemented M9 medium, but with 50 ,g of thymidine per ml and trimethoprim at levels of 5, 7.5, or 10 Wg/ml.
A turbid culture (5 x 108 cells/ml) was obtained after incubation for 65 h at 37 C in the tubes containing 5 ,ug of trimethoprim per ml; cultures grew more slowly in the presence of the higher concentrations of trimethoprim. Almost 50% of the colonies were able to grow on plates supplemented with thymine (10 jug/ml) but were unable to grow on plates without thymine. Any of these thymine-dependent strains which could grow on plates lacking thymine but supplemented with deoxyuridine were discarded. Finally, a strain called "SW-2" was selected and was found to contain no detectable thymidylate synthetase activity in either the spectrophotometric or radioactive assays. The thymidylate synthetase mutation in the SW-2 strain was stable (reversion rate less than 1 in 108 cells) and was not suppressed by amber suppressors. This was an important requirement so that during suppression of amber phage mutants a concurrent suppression of the host enzyme mutation would not occur.
Generalized transduction with bacteriophage P1 was employed to introduce known suppressor genes into the SW-2 strain. E. coli strains CA5013, CA161, and X7035, known to carry suI, suII, and suIII respectively, served as the donors. This procedure generated a set of strains which were isogenic except for the specific suppressor gene present. Transductants were tested for concomitant expression of suppression of their lac am and trp am markers, retention of thymine dependence, and ability to suppress known T4 amber phage ( Table 2 ). The SK-I strain (suI) was studied in detail.
Extraction and purification of phage thymidylate synthetase from T4D phage grown on E. coli 200 B. Preliminary experiments indicated that infection at a cell density of 1.5 x 108 cells/ml with a multiplicity of infection of 6 resulted in infection of more than 90% of the cells. Infective center assays detected progeny phage at 15 min; lysis followed this within 5 min. Thus experimental infections were terminated routinely at 15 min. Infected cell pellets from 39 liters of medium (see Materials and Methods) were sonically treated, centrifuged, and then fractionated as follows. Nucleic acids were removed by the addition of streptomycin (3. 75 mg per ml of extract) and this step was followed by two additions of (NH),2SO4, to 40 and 80% saturation. The enzyme present in the second (NH4)2SO4 fraction was redissolved and then concentrated by dialysis against solid sucrose.
Thymidylate synthetase was further purified by DEAE-cellulose chromatography either by gradient elution (0-0.34 M NaCl in Buffer A) or directly in a one-step elution with 0.08 M NaCl in Buffer A. As has been previously observed (6) , phage enzyme consistently appeared in earlier elution fractions than the host E. coli enzyme. When the isolated E. coli and phage enzymes were mixed and rechromatographed, two distinct peaks were again found, corresponding to the respective positions of the phage and host enzymes. Each of these peaks showed its original elution pattern when rechromatographed again. The final specific activities of seven purified phage T4D thymidyl- Different molecular weights of host and phage enzymes. The host and phage enzymes previously chromatographed on DEAE-cellulose emerged at different positions from a Sephadex G-100 column. In order to estimate their molecular weights, a Sephadex G-100 column (1 by 100 cm) was calibrated with proteins of known molecular weights: bovine gamma globulin, 160,000 (15); ovalbumin, 45,000 (21); and cytochrome c, 12,700 (12) . Phage thymidylate synthetase was eluted at a point corresponding to a molecular weight of 50,000; the host enzyme emerged in the region of 68,000. The results were reproducible in independent experiments. The average recoveryof active phage enzyme was 5% as compared to a recovery of 70% for the E. coli enzyme.
Different stabilities of host and phage thymidylate synthetases. The two enzymes exhibited markedly different stabilities and recoveries throughout the purification procedures. The recoveries of phage enzyme from ammonium sulfate fractionation, DEAE-cellulose chromatography, and Sephadex gel filtration were consistently lower than the recoveries of the host enzyme. The host enzyme, with specific activities up to 37 units of protein per mg, could be stored in sucrose at -20 C for a period of years with little loss of activity. Under any conditions employed, the phage enzyme decreased from a maximum specific activity of 10 units of protein per mg to 2 to 3 units/mg over a period of 18 To characterize an antiserum, measurements were made of its ability to inhibit the enzymatic activity of thymidylate synthetase from E. coli or phage T4. It was found that antiserum to phage T4 enzyme inhibited only phage T4 enzyme (Fig. 1) . Similarly, antiserum to host enzyme inhibited only host and not phage thymidylate synthetase (Fig. 1) . Neither normal serum nor the control antiserum to the protein in an E. coli strain lacking thymidylate synthetase (SW-2) inhibited either enzyme. Thus, the host and phage enzymes are immunologically distinct proteins.
Denatured enzyme cross-reacts with antiserum to homologous active thymidylate synthetase. Both the host and phage enzymes were inactivated gently. The host enzyme was heated to 45 C for 1 h; the phage enzyme was allowed to stand for 12 h at room temperature. Both of these inactive preparations were tested in their homologous and non-homologous enzyme-serum systems for their ability to compete with the active enzyme for inhibiting antibody. The net effect of a cross-reaction was to reduce the inhibitory effect of the antiserum on native enzyme.
Inactivated phage enzyme cross-reacted only with antiserum to phage thymidylate synthetase and not with antiserum to host enzyme, while inactivated host thymidylate synthetase cross-reacted only with anti-host enzyme serum and not with anti-phage enzyme serum ( Fig. 2  and 3) .
The fact that inactivated preparations could cross-react in their homologous systems indicated that loss of enzyme activity, possibly due to a local unfolding in the region of the catalytic site, could occur without a gross change in the tertiary structure of the protein.
The reciprocal lack of cross-reactivity with the heterologous serum showed that inactivation did not reveal any antigenically similar regions common to both the host and phage enzymes. possessing an amber mutation. Such an amber td would be expected to produce a small plaque xth active and inactivated phage thy-on a su-host but a large plaque on a su+ host in thetases react with antiserum to phage which the amber mutation was suppressed and h mixture consisted of 0.2 ml of diluted arious enzyme preparations as labeled. the phage gene could be expressed (see FIg. 4 ). of enzyme added were as follows: active Strains SW-2 (su-, SK-I (suns and SK-II (suII) s absorbance change per min at 340 nm) were sent to Irwin Tessman at Purdue Universi-.ted by standing at room temperature for ty, who screened his collection of td mutants for before inactivation); E. coli inactivated the predicted phenotype and returned 5 pret 45 C for 1 h, 0.030 before inactivation. sumptive td nonsense mutants (Table 2 ). In all 4 C each mixture was assayed spectro-cases in which the small plaque morphology was ily for thymidylate synthetase activity. produced (N33 and N37 infections of SW-2 and ag2 antiserum 242 + active T4D enzyme; SK-I; N43 and N54 infections of SW-2) no anti-phage enzyme serum 239 + active enzyme activity could be detected in the crude ain the presence of inactivated T4D extracts ( extracts. Appreciable enzymatic activity was detected in only one of the cases where a large plaque morphology occurred (N43 infections of SK-I). The most puzzling case was the N54 infection of SK-I, where no enzymatic activity could be detected even though large plaques were produced. Measurement of cross-reacting material produced by phage T4 td mutants on su-and su+ hosts. The immunoassay technique described above was used to measure the production of cross-reacting material in phage T4 td mutants grown on su-and su+ hosts. The presence of denatured thymidylate synthetase could be detected by reversal of the primary inhibition of active enzyme by antiserum. The results of such an experiment, depicted in Fig.  5 , show that there was a linear relationship between the reversal of inhibition and the amount of cross-reacting material present at any of the serum concentrations used.
Crude extracts from infections of the SW-2 (su-) and SK-I (su+) hosts with each of the phage td mutants were assayed in order to determine their content of cross-reacting material (Fig. 6) . Crude extracts of N33 infections of either SW-2 or SK-I contained no detectable cross-reacting material. Crude extracts of N37 infections of SW-2 and SK-I both contained one-third of the amount of wild-type crossreacting material. Thus none of these phage had the properties expected for simple amber mutants. No cross-reacting material was detected in crude extracts from N43 infections of the suhost SW-2. However, cross-reacting material was produced in N43 infections of the su+ host SK-I, so that this phage did behave as an amber mutant. The amount of this suppressed crossreacting material was less than that resulting from N37 infections. Similarly, although no cross-reacting material could be detected in crude extracts of N54 infections of SW-2, there assays are compatible with the tentative order of mapping presented above. That is, up to the point of termination, N33 produced no crossreacting material, while N37 produced a much more extended chain which could cross-react immunologically. A second possibility is that N33 and N37 are missense mutants. In the case of N33, the amino acid substitution in the protein would have to not only alter the nature of the catalytic site, rendering the enzyme inactive, but would also have to alter the conformation of the protein beyond what is achieved by mild denaturation, so that it is no longer cross-reactive. The N37 substitution may yield a cross-reactive protein with an altered and inactive catalytic site.
The tdN43 and tdN54 mutants are the only two studied that can be properly classified as amber mutants (Table 3) . First, they showed the expected phenotype: small plaques were produced on the SW-2 (su-) strain and large plaques appeared on the SK-I (su+) strain. Second, both produced more cross-reacting material during infection of the su+ host than during infection of the su-host. As expected, the crude extracts from infections of SW-2 contained no detectable enzymatic activity. Under conditions of suppression, thymidylate synthetase was produced upon infection with tdN43 giving one-sixth the specific activity of the wild-type phage infection. The amount of cross-reacting material closely paralleled the level of enzyme activity. In the tdN43 infections of SK-I, it is not possible to distinguish between two possibilities: the production of a small amount of active enzyme due to inefficient suppression or, second, the production of a large amount of partially active enzyme. If the latter were true, the substitution of serine in the protein chain resulted in an alteration of both the enzymatic activity and the protein conformation.
Surprisingly, no thymidylate synthetase activity was found in crude extracts from four independent infections of SK-I with tdN54 although the phage produced large plaques on SK-I. The substantial amount of cross-reacting material present in the crude extracts indicated that chain propagation had occurred and that the conformation of the resulting protein was not drastically altered. The absence of detectable enzymatic activity suggested two major possibilities. First, because of the particular site of the amber mutation, suppression may lead to an altered inactive catalytic site. Second, and more likely since the morphological tests indicated that thymidylate was being synthesized in vivo, the substitution of serine for the wildtype amino acid at the site of the amber mutation may have rendered the enzyme very labile to the conditions encountered during the preparation of the extracts.
Hall found that the map positions of tdN43 and tdN54 were indistinguishable; no wild-type recombinants were observed when a host was mixedly infected with these two mutants (D. Hall, personal communication). If tdN43 and tdN54 are indeed am mutations, then since the same suppressor mutation gave rise to different suppressed phenotypes, it is likely that the two mutations are in different codons. They may be so close to each other that recombination is a very rare event. The N54 site may be more critical for the formation of a stable catalytic site.
The tdN57 mutant represented a third type. This phage produced an intermediate size plaque on both SW-2 and SK-I strains. Correlated with this was a very low level of enzymatic activity. It was difficult to conclude that the tdN57 was an amber since the crossreacting material produced on infection of a su+ strain was only slightly higher than that produced on infection of a su-strain (Table 3) . Since no cross-reacting material was detected in crude extracts from tdN43 or tdN54 of SW-2 but was present with tdN57 infection, it appears that the tdN57 permitted the production of a protein chain which extended beyond the N43 or N54 sites and which had a conformation similar enough to the native enzyme to be immunologically active.
In summary, the ability to demonstrate differences in the properties of the enzyme thymidylate synthetase from cultures infected with phage td mutants of both amber and non-amber types allows one to conclude, in agreement with previous investigators, that the infecting T4 phage codes for the thymidylate synthetase which appears after infection. In the identification of true amber mutants, the immunological measurement of cross-reacting material was an effective indicator even when enzyme activity measurements alone were not sufficient, as with tdN54. As such mutants are identified, their thymidylate synthetase proteins should allow more detailed genetic mapping and further study of structure-function relationships as the effects of single specific amino acid replacements are defined.
